The Berkeleyan Spotlight: Rebecca Abergel
Removing a potential MRI risk – literally
October 21, 2021
Prof. Abergel had an article published in The Berkeleyan titled Removing a potential MRI risk – literally.
“The first use of MRI to scan a patient’s body was in 1977. Today, more than 40 million MRI scans are carried out every year in the U.S. In about one out of three, patients get an infusion containing the metal gadolinium as a contrast agent to improve imaging.
But over the last 10 to 15 years, physicians have increasingly reported that contrast MRIs sometimes lead to potentially life-threatening complications, particularly in patients with certain types of kidney disease. The FDA issued a warning against contrast MRIs for patients with kidney disease.” [read more]
Congratulations Professor Abergel